For instance, the targets of HRH1 miRNA were enriched in colorectal cancer, breast cancer, and melanoma, which were consistent with previous findings (Li et al., 2022; C. Park et al., 2023; Shi et al., 2019). This evidence concerns the gene HRH1 and breast cancer.